Recombinant Rat AXL Protein
Beta LifeScience
SKU/CAT #: BLK-03103P
Rat AXL on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Recombinant Rat AXL Protein
Beta LifeScience
SKU/CAT #: BLK-03103P
Collections: All products, High-quality recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
| Description | Recombinant Rat AXL Protein is expressed from HEK293 with His tag at the C-terminus.It contains Lys21-Pro434. |
| Gene Background | Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpression and activation of Axl receptor tyrosine kinase have been widely accepted to promote cell proliferation, chemotherapy resistance, invasion, and metastasis in several human cancers, such as lung, breast, and pancreatic cancers. |
| Accession | Q8VI99 |
| Target Symbol | AXL |
| Synonyms | Axl; UFO; AXL oncogene; AXL; ARK; JTK11; Tyro7; AI323647; EC 2.7.10; EC 2.7.10.1 |
| Species | Rat |
| Expression System | Mammalian Cell |
| Purity | > 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC |
| Tag | C-His |
| Expression Range | Lys21-Pro434 |
| Mol. Weight | The protein has a predicted MW of 46.88 kDa. Due to glycosylation, the protein migrates to 65-80 kDa based on Bis-Tris PAGE result. |
| Form | Liquid |
| Formulation | Supplied as 0.22 um filtered solution in PBS (pH 7.4). |
| Endotoxin | Less than 1 EU per ug by the LAL method. |
| Biotinylated | No |
| Shipping | Shipped with dry ice. |
| Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
